Article Text

Download PDFPDF
Effectiveness of recombinant human granulocyte macrophage colony-stimulating factor for treating deep second-degree burns: a systematic review and meta-analysis
  1. Jiamei Li,
  2. W Liu,
  3. G Zhang,
  4. D Wang,
  5. H Lou and
  6. J Duang
  1. Department of Burns, Kunming Medical University Second Hospital, Kunming, Yunnan, China
  1. Correspondence to Professor W Liu, burns, Kunming Medical University Second Hospital, Kunming, Yunnan, China; 86550558{at}qq.com

Abstract

Introduction It is uncertain whether treatment by recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) can promote healing of deep second-degree burns. This meta-analysis aimed to systematically review and assess randomised controlled trials (RCTs) that investigated the efficacy and safety of rhGM-CSF for treating deep second-degree burns.

Methods This meta-analysis conformed to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement. The PubMed, Cochrane Library, Medline and Embase databases and relevant references were systematically searched for RCTs (published up to November 2019). Main outcome measures included the wound healing rate, wound healing time and average optical densities of the vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF). We performed a meta-analysis using fixed or random effects models.

Results Seven RCTs comprising 982 patients with 1184 burns (652 patients received rhGM-CSF vs 532 controls) were included. Compared with standard wound care alone, the use of rhGM-CSF significantly reduced wound healing time by 4.77 days (weighted mean difference=−4.77; 95% CI −6.45 to −3.09; p<0.001) and significantly increased the wound healing rate on days 7, 10, 14 and 20 by 6.46%, 19.78%, 17.07% and 11.38%, respectively. There was no significant difference between the groups in the wound healing rate on day 28 and average optical densities of VEGF and FGF. No systematic adverse event occurred. Redder, more swollen and painful wounds were reported after using rhGM-CSF compared with the control.

Conclusions rhGM-CSF could be effective and safe for treating deep second-degree burns.

  • surgical dermatology
  • trauma management
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors JL and WL were major contributors in writing the manuscript and revising it for important contents of manuscript. All authors read and approved the final manuscript.

  • Funding Project supported by the National Natural Science Foundation of China, number: 81660319.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article or uploaded as supplementary information.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.